Galecto, Inc. (DMRA) vs Syndax Pharmaceuticals, Inc. (SNDX)
- Galecto, Inc. DMRA 18.42 −1.71%
- Syndax Pharmaceuticals, Inc. SNDX 12.88 −5.64%
Galecto, Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Galecto, Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($1.2B and $1.2B). Galecto, Inc. has the higher net margin (0.00% vs −87.6%) and the higher return on invested capital (0.00% vs −247.9%). Across the 14 metrics below, Galecto, Inc. leads on 10 and Syndax Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | DMRA | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 95.78% | 65.16% |
| Operating margin | 0.00% | (77.05%) | 0.00% |
| Net margin | 0.00% | (87.60%) | 0.00% |
| Free cash flow margin | 0.00% | (87.64%) | 0.00% |
| Return on equity | (26.26%) | (255.93%) | (56.36%) |
| Return on assets | (18.64%) | (33.97%) | (48.04%) |
| Return on invested capital | 0.00% | (247.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack